Healthcare Sales & Marketing Network News: Opexa Therapeutics

Searching News Database: Opexa Therapeutics

HSMN NewsFeed - 12 Sep 2019
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2015
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 5 Feb 2013
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna(TM) (imilecleucel-T) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 21 May 2012
Opexa Therapeutics Announces Tcelna(TM) as New Brand Name for MS Therapy
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Dec 2009
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin(R) Development in Multiple Sclerosis
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 5 Feb 2009
Cytomedix Further Strengthens Its Board of Directors
Devices Wound Care Personnel

HSMN NewsFeed - 21 Mar 2008
Opexa Therapeutics Announces Retirement of CEO David McWilliams
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 May 2007
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.